University of Pennsylvania
Dr. Ky is an Associate Professor of Medicine and Epidemiology and physician scientist at the University of Pennsylvania. Her overarching goals are to gain insight into the underlying mechanisms and predictors of cancer therapy cardiotoxicity and heart failure, and to translate this understanding to the clinical care of patients. Dr. Ky leads a translational research program in cardio-oncology and is the PI of multiple cohort studies and clinical trials focused on the study of the cardiotoxic effects of doxorubicin, trastuzumab, sunitinib, and radiation therapy in breast, renal cell, and lung cancers and lymphoma patients. She is also Director for the Penn Center for Quantitative Echocardiography and of the Penn Cardio-Oncology Center of Excellence. In addition, she is an invited member of many cardio-oncology expert consensus and research groups within the NIH, FDA, American Society of Clinical Oncology, ACC, AHA, and ESC focused on advancing our understanding of cardiovascular disease in the growing cancer population. Dr. Ky is Editor-in-Chief of JACC CardioOncology and is a member of the Sarnoff Cardiovascular Research Foundation Scientific Committee.